Dorner F - Search Results

1

Immunization of chimpanzees with recombinant gp160, but not infection with human immunodeficiency virus type 1, induces envelope-specific Th1 memory cells.

Mannhalter JW, Fischer MB, Wolf HM, Küpcü Z, Barrett N, Dorner F, Eder G, Eibl MM. Mannhalter JW, et al. Among authors: dorner f. J Infect Dis. 1995 Feb;171(2):437-40. doi: 10.1093/infdis/171.2.437. J Infect Dis. 1995. PMID: 7844384

2

Immunization of chimpanzees with the HIV-1 glycoprotein gp160 induces long-lasting T-cell memory.

Mannhalter JW, Pum M, Wolf HM, Küpcü Z, Barrett N, Dorner F, Eder G, Eibl MM. Mannhalter JW, et al. Among authors: dorner f. AIDS Res Hum Retroviruses. 1991 May;7(5):485-93. doi: 10.1089/aid.1991.7.485. AIDS Res Hum Retroviruses. 1991. PMID: 1714748

3

Characterization of a vaccinia-derived recombinant HIV-1 gp160 candidate vaccine and its immunogenicity in chimpanzees.

Barrett N, Eder G, Dorner F. Barrett N, et al. Among authors: dorner f. Biotechnol Ther. 1991;2(1-2):91-106. Biotechnol Ther. 1991. PMID: 1845126

4

Large-scale production and purification of a vaccinia recombinant-derived HIV-1 gp160 and analysis of its immunogenicity.

Barrett N, Mitterer A, Mundt W, Eibl J, Eibl M, Gallo RC, Moss B, Dorner F. Barrett N, et al. Among authors: dorner f. AIDS Res Hum Retroviruses. 1989 Apr;5(2):159-71. doi: 10.1089/aid.1989.5.159. AIDS Res Hum Retroviruses. 1989. PMID: 2713166

5

The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients.

Gerencer M, Burek V, Crowe BA, Barrett NP, Dorner F. Gerencer M, et al. Among authors: dorner f. Microb Pathog. 1998 Nov;25(5):253-66. doi: 10.1006/mpat.1998.0233. Microb Pathog. 1998. PMID: 9878454

6

[AIDS vaccines: an enigma in vaccine development].

Dorner F, Barrett N. Dorner F, et al. Wien Klin Wochenschr. 1990 Jan 19;102(2):51-8. Wien Klin Wochenschr. 1990. PMID: 1689919 Review. German.

7

A novel mammalian cell (Vero) derived influenza virus vaccine: development, characterization and industrial scale production.

Kistner O, Barrett PN, Mundt W, Reiter M, Schober-Bendixen S, Eder G, Dorner F. Kistner O, et al. Among authors: dorner f. Wien Klin Wochenschr. 1999 Mar 12;111(5):207-14. Wien Klin Wochenschr. 1999. PMID: 10226351

8

Development of a Vero cell-derived influenza whole virus vaccine.

Kistner O, Barrett PN, Mundt W, Reiter M, Schober-Bendixen S, Eder G, Dorner F. Kistner O, et al. Among authors: dorner f. Dev Biol Stand. 1999;98:101-10; discussion 111. Dev Biol Stand. 1999. PMID: 10494963

9

Humoral and cell-mediated immunity to vero cell-derived influenza vaccine.

Brühl P, Kerschbaum A, Kistner O, Barrett N, Dorner F, Gerencer M. Brühl P, et al. Among authors: dorner f. Vaccine. 2000 Dec 8;19(9-10):1149-58. doi: 10.1016/s0264-410x(00)00316-9. Vaccine. 2000. PMID: 11137251

10

Efficiency of the polymerase chain reaction for the detection of human immunodeficiency virus type (HIV-1) DNA in the lymphocytes of infected persons: comparison to antigen-enzyme-linked immunosorbent assay and virus isolation.

Stoeckl E, Barrett N, Heinz FX, Banekovich M, Stingl G, Guggenberger K, Dorner F, Kunz C. Stoeckl E, et al. Among authors: dorner f. J Med Virol. 1989 Dec;29(4):249-55. doi: 10.1002/jmv.1890290406. J Med Virol. 1989. PMID: 2621451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters